Ubs Group Ag United Therapeutics Corp Transaction History

Ubs Group Ag

$582 Billion
Q4 2025

A detailed history of Ubs Group Ag transactions in United Therapeutics Corp stock. As of the latest transaction made, Ubs Group Ag holds 225,849 shares of UTHR stock, worth $105 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

225,849

Previous 155,404 45.33%

Holding current value

$105 Million

Previous $65.1 Million 61.69%

% of portfolio

0.02%

Previous 0.01%

36 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2025 Jan 29, 2026	BUY	$415.34 - $466.4 $29.3 Million - $32.9 Million	70,445 Added 45.33%	225,849 $105 Million
Q3 2025 Nov 13, 2025	BUY	$274.7 - $438.75 $14.1 Million - $22.5 Million	51,290 Added 49.26%	155,404 $65.1 Million
Q2 2025 Aug 14, 2025	SELL	$276.47 - $328.4 $8.07 Million - $9.59 Million	-29,203 Reduced 21.9%	104,114 $29.9 Million
Q1 2025 May 13, 2025	BUY	$304.42 - $380.78 $11.6 Million - $14.6 Million	38,251 Added 40.24%	133,317 $41.1 Million
Q4 2024 Feb 14, 2025	SELL	$348.66 - $410.0 $1.42 Million - $1.67 Million	-4,071 Reduced 4.11%	95,066 $33.5 Million

Q3 2024 Nov 14, 2024	BUY	$311.04 - $363.55 $5.4 Million - $6.31 Million	17,361 Added 21.23%	99,137 $35.5 Million
Q2 2024 Aug 13, 2024	BUY	$228.26 - $319.04 $488,248 - $682,426	2,139 Added 2.69%	81,776 $26 Million
Q1 2024 May 13, 2024	BUY	$210.76 - $249.51 $3.15 Million - $3.73 Million	14,963 Added 23.14%	79,637 $18.3 Million
Q4 2023 Feb 09, 2024	BUY	$214.88 - $256.94 $1.51 Million - $1.8 Million	7,020 Added 12.18%	64,674 $14.2 Million
Q3 2023 Nov 09, 2023	SELL	$211.82 - $248.24 $525,525 - $615,883	-2,481 Reduced 4.13%	57,654 $13 Million
Q2 2023 Aug 11, 2023	SELL	$205.19 - $232.99 $1.34 Million - $1.52 Million	-6,544 Reduced 9.81%	60,135 $13.3 Million
Q1 2023 May 12, 2023	BUY	$212.99 - $276.17 $2.49 Million - $3.23 Million	11,679 Added 21.23%	66,679 $14.9 Million
Q4 2022 Feb 08, 2023	BUY	$205.95 - $280.43 $2.66 Million - $3.62 Million	12,901 Added 30.64%	55,000 $15.3 Million
Q3 2022 Nov 10, 2022	SELL	$203.3 - $244.17 $5.22 Million - $6.27 Million	-25,694 Reduced 37.9%	42,099 $8.82 Million
Q2 2022 Aug 10, 2022	BUY	$174.81 - $241.14 $2.46 Million - $3.4 Million	14,087 Added 26.23%	67,793 $16 Million
Q1 2022 May 16, 2022	SELL	$166.16 - $213.96 $5.27 Million - $6.79 Million	-31,733 Reduced 37.14%	53,706 $9.64 Million
Q4 2021 Feb 14, 2022	BUY	$184.32 - $216.08 $7.33 Million - $8.6 Million	39,794 Added 87.18%	85,439 $18.5 Million
Q3 2021 Nov 15, 2021	SELL	$179.86 - $214.88 $11.8 Million - $14.1 Million	-65,778 Reduced 59.03%	45,645 $8.43 Million
Q2 2021 Aug 13, 2021	BUY	$170.47 - $211.93 $11.7 Million - $14.6 Million	68,746 Added 161.08%	111,423 $20 Million
Q1 2021 May 12, 2021	BUY	$153.94 - $174.85 $3.47 Million - $3.94 Million	22,510 Added 111.62%	42,677 $7.14 Million
Q4 2020 Feb 11, 2021	SELL	$101.87 - $151.79 $3.89 Million - $5.8 Million	-38,234 Reduced 65.47%	20,167 $3.06 Million
Q3 2020 Nov 12, 2020	BUY	$99.9 - $121.13 $1.9 Million - $2.3 Million	18,981 Added 48.15%	58,401 $5.9 Million
Q2 2020 Jul 31, 2020	BUY	$92.74 - $125.82 $3.55 Million - $4.82 Million	38,308 Added 3444.96%	39,420 $4.77 Million
Q1 2020 May 01, 2020	SELL	$79.39 - $115.35 $111,463 - $161,951	-1,404 Reduced 55.8%	1,112 $106,000
Q4 2019 Feb 14, 2020	SELL	$78.31 - $95.34 $4.27 Million - $5.2 Million	-54,558 Reduced 95.59%	2,516 $221,000
Q3 2019 Nov 14, 2019	BUY	$74.85 - $85.99 $3.87 Million - $4.44 Million	51,670 Added 956.14%	57,074 $4.55 Million
Q2 2019 Aug 14, 2019	SELL	$76.06 - $120.81 $6.38 Million - $10.1 Million	-83,944 Reduced 93.95%	5,404 $422,000
Q1 2019 May 14, 2019	SELL	$107.15 - $126.84 $2.41 Million - $2.85 Million	-22,504 Reduced 20.12%	89,348 $10.5 Million
Q4 2018 Feb 14, 2019	BUY	$101.4 - $128.73 $9.57 Million - $12.1 Million	94,367 Added 539.7%	111,852 $12.2 Million
Q3 2018 Nov 14, 2018	BUY	$113.81 - $129.46 $1.58 Million - $1.8 Million	13,914 Added 389.64%	17,485 $2.24 Million
Q2 2018 Aug 14, 2018	SELL	$101.14 - $118.31 $5.53 Million - $6.46 Million	-54,630 Reduced 93.86%	3,571 $404,000
Q1 2018 May 15, 2018	BUY	$107.21 - $151.94 $5.48 Million - $7.76 Million	51,092 Added 718.69%	58,201 $6.54 Million
Q4 2017 Feb 14, 2018	SELL	$118.58 - $151.28 $1.35 Million - $1.72 Million	-11,369 Reduced 61.53%	7,109 $1.05 Million
Q3 2017 Nov 14, 2017	SELL	$114.6 - $136.81 $213,385 - $254,740	-1,862 Reduced 9.15%	18,478 $2.17 Million
Q2 2017 Aug 14, 2017	SELL	N/A	-9,088 Reduced 30.88%	20,340 $2.64 Million
Q1 2017 Nov 14, 2017	BUY	N/A	29,428	29,428 $3.98 Million

Others Institutions Holding UTHR

# of Institutions

839

Shares Held

41.6M

Call Options Held

1.56M

Put Options Held

2.86M

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $21.2B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account